Home＞ACADEMIA
Positioning of Abraxane and Anti-PD-1 Antibodies Will Be Focus of Interest in Revised Guidelines for Gastric Cancer(Mar.23.2016)
The Japanese Gastric Cancer Association (JGCA) is revising the guidelines for the treatment of gastric cancer. Evidence from a number of clinical trials to be announced going forward is expected to be reflected in the revised guidelines’ recommendations on chemotherapy. It plans to announce the revised guidelines in 2017, which would be the third year since their last revision ...
(LOG IN FOR FULL STORY)
-
- Clinical Trials for Mitochondrial Disease Heating Up with AMED’s Support; Filing for First Hyperlactacidemia Drug Expected in 2020 Apr.23
- Expert Cautions against Hasty Discussions on Cost Effective Assessments Apr.20
- Biosimilar Use Essential to Sustain Universal Health Coverage: Society President Apr.19
-
Physicians Association Initiates Large-Scale Study to Directly Compare DPP-4 Inhibitors to SGLT2 Inhibitors, Determine “Optimal Patients” for Each
Apr.19
-
Lynparza Desirable for Use in Early-Stage Maintenance Therapy: Jikei Univ. Prof.
Apr.02
- Japan Trains Sight on CEA as Centerpiece of This Year’s Cost Containment Efforts(Apr.23)
- Japan Ethical Drug Sales in 54 Fields Shrink 1.6% in 2017(Apr.23)
- Clinical Trials for Mitochondrial Disease Heating Up with AMED’s Support; Filing for First Hyperlactacidemia Drug Expected in 2020(Apr.23)
- Takeda Sweetens Bid for Shire, Ups Cash Component(Apr.23)
- No Dialogue at New “Public-Private Dialogue” Confab with Limited Time, JPMA Says(Apr.20)
